Skip to main content
. Author manuscript; available in PMC: 2013 Apr 1.
Published in final edited form as: Biomaterials. 2012 Jan 14;33(10):2952–2960. doi: 10.1016/j.biomaterials.2011.12.043

Figure 4. Pathways of cellular uptake for C60-serPF.

Figure 4

Panel A. C60-serPF internalization in Hep3B cells is susceptible to inhibitors of macropinocytosis (DMA) and dynamin-dependent, clathrin-mediated pathway (dynamin and chlorpromazine). Panel B. Uptake of C60-serPF in Huh7 cells is inhibited by inhibitors of macropinocytosis (DMA) and dynamin-dependent, caveolin/ lipid-raft-mediated pathway (Dynamin, nystatin and MBCD).